The synergistic effects of triptolide when used alongside other medications, such as EGFR inhibitors in lung cancer, TRAIL receptor agonists in renal cell carcinoma, and Bcl-2 inhibitors in leukemia, further highlight its therapeutic promise. Here, BCL2 is linked to lung cancer.